AlphAIAlphAI — Financial news for AI agents
investing.comOCT 282 min read$XYL

Goldman Sachs reiterates Buy on Xylem stock despite guidance cut

Goldman Sachs maintained a Buy rating and $138 price target for Xylem (NYSE:XYL) despite its Q3 2026 revenue miss and lowered guidance. Xylem's stock is down 31% YTD. The company reduced its fiscal 2026 organic revenue growth outlook to flat and adjusted EPS guidance to $5.40-$5.45. JPMorgan downgraded XYL to Underweight, while RBC cut its price target to $125 but kept an Outperform rating.

Original reporting
investing.com
Published Oct 28, 2026, 9:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$XYL
Bearish
high confidence
Mentioned
$XYL
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$XYLBearishMed
01

Why it matters

The earnings miss and guidance downgrade are new information that can affect pricing, while analyst upgrades provide a mixed signal.

02

Market read

Xylem's earnings and guidance revision provide fresh material for traders; mixed analyst reactions create a nuanced outlook.

03

What to watch

Potential upside from data‑center demand and portfolio actions shifting toward higher‑margin end markets.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Xylem reported Q3 2026 results with revenue slightly above forecasts but earnings just missing estimates, and it lowered its full‑year organic revenue growth outlook to flat.

Company-level read

Ticker impact

$XYLBearishHigh confidence
Context

Goldman Sachs reiterates Buy on Xylem after the company reported Q3 results with a guidance cut and lowered full-year outlook.

Expected impact

likely pressure as the market prices in the reduced revenue and earnings guidance

Evidence & confidence

The earnings release includes new, material numbers and a downward revision of full-year guidance, which historically triggers downside moves.

Market effects

Sector

Water infrastructure and utility sector may see broader scrutiny as Xylem signals slower demand and project timing issues.

Regional

U.S. industrial and utility stocks could face modest downside pressure.

Global

Limited to investors tracking water‑tech and industrial equipment exposure.

Counterpoint

What could challenge this read

Goldman Sachs maintains a Buy rating, suggesting the stock may be undervalued and could rebound if the market overreacts to the guidance cut.

Key entities

  • analyst
    Goldman Sachs

    Reiterated Buy rating and $138 price target on Xylem.

  • analyst
    JPMorgan

    Downgraded Xylem to Underweight.

  • analyst
    RBC Capital

    Reduced price target to $125.

Read at source← All news

StoryXylem cuts FY 2026 revenue outlook, lowers EPS guidance and announces divestitures and segment restructure

Also covered by

4 outlets

Related articles

OCT 28
$XYLHigh

JPMorgan downgrades Xylem stock rating on guidance cut, slower orders

JPMorgan downgraded Xylem (NYSE:XYL) to Underweight, cutting its price target to $90.00 from $118.00. The company's Q3 results missed estimates, leading to lowered 2026 guidance due to slower revenue conversion. Xylem's stock is near its 52-week low, down 37% over the past year. The company announced a 2027 re-segmentation to improve strategic focus. JPMorgan expects underperformance over the next 12 months but notes long-term value for sustainability-focused investors.

investing.com2 min
OCT 27
$XYLMedAI 8/10

Xylem (XYL) Q3 2026 Earnings Call Transcript

Xylem (XYL) reported Q3 2026 orders of $2.3B (+10% organic), revenue of $2.2B (flat organic), and adjusted EPS of $1.44 (+5%). Backlog grew 13% to $5.5B. Guidance: FY revenue ~$8.95B (flat organic), FY adjusted EPS $5.40-$5.45. Q4 revenue expected to decline 1-2% organic. Plans divestitures and segment reorganization.

fool.com3 min
OCT 27
$XYLMed

Xylem Inc. Q3 2026 Earnings Call Summary

Xylem Inc. reported Q3 2026 revenue shortfall due to cautious utility spending. The company plans to divest non-core assets, reducing China exposure, and restructure into three segments in 2027. Despite lower full-year guidance, EBITDA margins expanded by 70 basis points. Management highlighted growth in data centers and semiconductor sectors, with data center revenue expected to reach 2% of total revenue by year-end.

finance.yahoo.com3 min